Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIRECT: Disulfiram as add-on to Chemotherapy in Recurrent Glioblastoma
NCT02678975Phase 3Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jan 2017
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of disulfiram in glioblastoma (GBM), sponsored by Sahlgrenska University Hospital. Started Jan 2017; status: completed.
02
Drugs
disulfiram
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02678975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678975.